BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Flunarizine

a selective calcium entry blocker with calmodulin binding properties and histamine H1 blocking activity. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy.

299+ PubMed studies analyzed · 31 RCTs · Evidence Score: 46.9

Research Domains

Flunarizine has been studied across 20 research domains including 💊 Pain, 🦴 Bone & Joint, 🌤️ Mood & Depression, 🧠 Focus & Attention, 🧠 Neuroprotection. The primary research focus is 💊 Pain with 35% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Flunarizine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Cinnarizine
31 shared targets
Promethazine
34 shared targets
Nortriptyline
33 shared targets
Metergoline
36 shared targets
Cyproheptadine
32 shared targets
Maprotiline
30 shared targets
Amitriptyline
33 shared targets
Mianserin
29 shared targets
Domperidone
28 shared targets
Quetiapine
24 shared targets
Loading evidence profile...

This evidence profile for Flunarizine is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.